$SNSS new volume upturn $2.07 www.sunesis.com/
Post# of 63703
Posted On: 11/19/2014 1:55:25 PM
$SNSS new volume upturn $2.07
Wbsite
Recent Trades
Shares Outstanding: 61.95M
Float: 36.78M
% Held by Insiders1: 18.15%
% Held by Institutions1: 82.10%
Shares Short (as of Oct 31, 2014)3: 6.38M
Short Ratio (as of Oct 31, 2014)3: 1.50
Short % of Float (as of Oct 31, 2014)3: 17.20%
Shares Short (prior month)3: 6.16M
10-Q 11/10/14
Summary
Headlines
Wednesday, November 19, 2014
7:01 am Sunesis Pharma announces publication of Vosaroxin Phase 1b/2 AML trial results in Haematologica; vosaroxin, in combination with cytarabine, is active and well toleratedBriefing.com (Wed 7:01AM EST)
Sunesis Announces Publication of Vosaroxin Phase 1b/2 AML Trial Results in HaematologicaGlobeNewswire (Wed 7:00AM EST)
Tuesday, November 18, 2014
SUNESIS PHARMACEUTICALS INC FinancialsEDGAR Online Financials
Sunesis Pharmaceuticals (SNSS) Jumps: Stock Surges 38.3%Zacks
Monday, November 17, 2014
Is This the Sunesis Resurrection?at 24/7 Wall St.
Sunesis Pharmaceuticals Bounces On Results Announcementat TheStreet
Sunesis Pharmaceuticals (SNSS) Stock Surges on Upcoming Announcement of Blood Cancer Treatment Dataat TheStreet
Sunesis Pharmaceuticals Announces Late-Breaking Presentation of Phase 3 VALOR Trial at ASH Annual MeetingGlobeNewswir
Wednesday, November 12, 2014
10-Q for Sunesis Pharmaceuticals, Inc.Company Spotlight
Monday, November 10, 2014
Sunesis Pharmaceuticals Inc Earnings Call scheduled for 10:30 am ET todayCCBN
SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements aEDGAR Online
Sunesis Pharmaceuticals Reports Third Quarter 2014 Financial Results and Recent HighlightsGlobeNewswire
Wednesday, November 5, 2014
Sunesis to Present at Upcoming Investor ConferencesGlobeNewswire
Monday, November 3, 2014
Sunesis to Host Conference Call on November 10th to Discuss Third Quarter 2014 Financial Results and Recent HighlightsGlobeNewswire\
Wednesday, October 22, 2014
Citadel Advisors adds to its position in Sunesis PharmaceuticalsMarket Realist
Wednesday, October 15, 2014
Sunesis Pharmaceuticals (SNSS) Jumps: Stock Gains 8.5%Zacks
Wednesday, October 8, 2014
Biotech Stock Roundup: Sunesis Tanks on Study Results, Chimerix Up on Ebola UpdateZacks
Tuesday, October 7, 2014
Sunesis Pharmaceuticals, Inc.'s Flop: More Drugs Out There, Says RothBenzinga
Sunesis Pharmaceuticals Down on Failure of Trial on QinprezoZacks
It's True, Small-Cap Biotech Stocks Are Acting Badly These Daysat TheStreet
Wbsite
Recent Trades
Shares Outstanding: 61.95M
Float: 36.78M
% Held by Insiders1: 18.15%
% Held by Institutions1: 82.10%
Shares Short (as of Oct 31, 2014)3: 6.38M
Short Ratio (as of Oct 31, 2014)3: 1.50
Short % of Float (as of Oct 31, 2014)3: 17.20%
Shares Short (prior month)3: 6.16M
10-Q 11/10/14
Summary
Headlines
Wednesday, November 19, 2014
7:01 am Sunesis Pharma announces publication of Vosaroxin Phase 1b/2 AML trial results in Haematologica; vosaroxin, in combination with cytarabine, is active and well toleratedBriefing.com (Wed 7:01AM EST)
Sunesis Announces Publication of Vosaroxin Phase 1b/2 AML Trial Results in HaematologicaGlobeNewswire (Wed 7:00AM EST)
Tuesday, November 18, 2014
SUNESIS PHARMACEUTICALS INC FinancialsEDGAR Online Financials
Sunesis Pharmaceuticals (SNSS) Jumps: Stock Surges 38.3%Zacks
Monday, November 17, 2014
Is This the Sunesis Resurrection?at 24/7 Wall St.
Sunesis Pharmaceuticals Bounces On Results Announcementat TheStreet
Sunesis Pharmaceuticals (SNSS) Stock Surges on Upcoming Announcement of Blood Cancer Treatment Dataat TheStreet
Sunesis Pharmaceuticals Announces Late-Breaking Presentation of Phase 3 VALOR Trial at ASH Annual MeetingGlobeNewswir
Wednesday, November 12, 2014
10-Q for Sunesis Pharmaceuticals, Inc.Company Spotlight
Monday, November 10, 2014
Sunesis Pharmaceuticals Inc Earnings Call scheduled for 10:30 am ET todayCCBN
SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements aEDGAR Online
Sunesis Pharmaceuticals Reports Third Quarter 2014 Financial Results and Recent HighlightsGlobeNewswire
Wednesday, November 5, 2014
Sunesis to Present at Upcoming Investor ConferencesGlobeNewswire
Monday, November 3, 2014
Sunesis to Host Conference Call on November 10th to Discuss Third Quarter 2014 Financial Results and Recent HighlightsGlobeNewswire\
Wednesday, October 22, 2014
Citadel Advisors adds to its position in Sunesis PharmaceuticalsMarket Realist
Wednesday, October 15, 2014
Sunesis Pharmaceuticals (SNSS) Jumps: Stock Gains 8.5%Zacks
Wednesday, October 8, 2014
Biotech Stock Roundup: Sunesis Tanks on Study Results, Chimerix Up on Ebola UpdateZacks
Tuesday, October 7, 2014
Sunesis Pharmaceuticals, Inc.'s Flop: More Drugs Out There, Says RothBenzinga
Sunesis Pharmaceuticals Down on Failure of Trial on QinprezoZacks
It's True, Small-Cap Biotech Stocks Are Acting Badly These Daysat TheStreet
(0)
(0)Scroll down for more posts ▼